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Case Report
A Case of Robot-Assisted Laparoscopic Radical Prostatectomy in 
Primary Small Cell Prostate Cancer
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Department of Urology, National Health Insurance Corporation Ilsan Hospital, Goyang, 1Urologic Science Institute, Yonsei University 
College of Medicine, Seoul, 2Inje University Haeundae Paik Hospital, Busan, Korea
Primary small cell carcinoma of the prostate is a rare and very aggressive disease with 
a poor prognosis, even in its localized form. We managed a case of primary small cell 
carcinoma of the prostate. The patient was treated with robot-assisted laparoscopic 
radical prostatectomy and adjuvant chemotherapy. Herein we report this first case of 
robot-assisted laparoscopic radical prostatectomy performed in a patient with primary 
small cell carcinoma of the prostate. 
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Primary small cell carcinoma of the prostate is very rare, 
accounting for less than 2% of all prostate cancer cases [1]. 
It shows a very poor prognosis, and small cell cancer is con-
firmed in approximately 10% to 20% of deaths after the 
treatment of prostate adenocarcinoma [2]. The average age 
of onset has been reported to be 66 to 69 years; however, 
the range is broad from 24 to 92 years of age [1,2]. About 
half of the patients with primary small cell carcinoma of 
the prostate complain of symptoms due to bladder outlet 
obstruction, and one third of them complain of weight loss, 
anorexia, neurological symptoms, flank pain, and back 
pain [3]. The diagnosis is confirmed by a positive response 
to immunoperoxidase staining and neurosecretory gran-
ules visible by electron microscope. 
    We treated a patient surgically by robot-assisted laparo-
scopic prostatectomy after a diagnosis of primary small cell 
prostate cancer by transurethral resection of the prostate 
(TURP) and prostate biopsy due to acute urinary retention. 
Here we report this case together with a review of the 
literature.
CASE REPORT
A 66-year-old male patient visited the urology clinic in an-
other hospital because of acute urinary retention. His med-
ical history included hypertension without any specific 
family history. His prostate-specific antigen (PSA) level 
and prostate volume as measured at the initial visit were 
1.19 mg/ml (TandemR-R PSA immunoradiometric assay) 
and 53 g, respectively. The hard prostate was palpated by 
digital rectal examination, without any palpable masses, 
and there were no abnormal findings except for a white 
blood cell (WBC) count of 3-5/high power field (HPF) and 
a red blood cell (RBC) count of 3-5/HPF in the urine 
analysis. No abnormal findings were reported for the com-
plete blood cell count, biochemistry indexes, and simple ra-
diologic exam. In May 2009, TURP was performed on this 
patient, and abdominal pelvic computed tomography (CT) 
(Fig. 1), chest CT, and whole-body bone scan were also per-
formed because the pathology results indicated small cell 
cancer. In the abdominal pelvic CT, multiple lymphadeno-
pathies that were assumed to be metastatic lesions were 
observed near the bilateral iliac chain. No metastatic le-
sions were found on the chest CT or whole-body bone scan. 
To treat the primary small cell carcinoma of the prostate, 
the patient was admitted for robot-assisted laparoscopic 
radical prostatectomy with adjuvant chemotherapy after 
transfer to the urology clinic in our hospital. 
    We performed magnetic resonance imaging (MRI) in or-
der to check the cancer stage. In the prostate MRI, the ma-
lignant lesion of the prostate was observed to invade the 
right capsule and seminal vesicles (Fig. 2). In July 2009, 
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FIG. 1. Abdominal pelvic computed tomography (CT) scan: lymph-
adenopathy and right pelvic dilatation, which were assumed to
be metastatic lesions near both iliac arteries, were observed.
FIG. 3. Gross appearance of the resected tumor.
FIG. 2. Prostate magnetic resonance imaging (MRI): A malignant
lesion of the prostate was observed showing penetration into the
right capsule and seminal vesicles.
FIG. 4. The microscopic findings show diffuse small round cells 
with scanty cytoplasm (H&E, x200).
the patient underwent robot-assisted laparoscopic radical 
prostatectomy and extended pelvic lymph node dissection; 
the bilateral nerves were not saved. The total operative 
time was 240 minutes, and the amount of blood loss was 
250 cc. The drainage tube was removed on day 3 after sur-
gery, and the patient was discharged without any post-
operative complications on day 4. The pathologic results 
showed small cell carcinoma invading the capsule of the 
prostate (Fig. 3, 4) and also metastasis of carcinoma in the 
right external iliac lymph nodes and right obturator lymph 
nodes. The weight of the prostate was 57 g, and the intra-
glandular tumor volume was 21 cc. The tumor involved 
both lobes, but the resection margin was not involved by 
the tumor. On postoperative day 7, the catheter was re-
moved in the urology clinic. After brain MRI confirmed no 
metastatic lesions, adjuvant chemotherapy was started 
with VP-16 100 mg/m2 and cisplatin 80 mg/m2 on day 30. 
Adjuvant chemotherapy has been performed 8 times for 9 
months since the operation. The multiple lymphadeno-
pathies that had been observed before the surgery im-
proved and there is currently no evidence of remnant 
disease. 
DISCUSSION
Extrapulmonary small cell cancers are observed in the 
head and neck, skin, gastrointestinal system, cervix, and 
so on, but they are very rare, accounting for 0.1% to 0.4% 
of all malignant tumors [4] and approximately 5% of all 
small cell cancers. In the urological system, there have 
been case reports in the kidney, bladder, and prostate [5]. 
Small cell cancer of the prostate is known to occur as the 
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result of changes in the argyrophil cells and argentaffin 
cells that exist in the normal prostate [6]. However, the hy-
pothesis that small cell cancer of the prostate occurs with 
the differentiation of various protocells is now convincing 
[7,8], showing coexistence with prostate adenoma or past 
history of prostate adenoma and positive responses [9] in 
prostatic acid phosphatase and PSA. The proper treatment 
guidelines for small cell prostate cancer are unclear owing 
to its low prevalence and an insufficiency of studies com-
pared with typical prostate adenocarcinoma. It has been 
reported that only radical prostatectomy shows ther-
apeutic effects on early small cell cancer in the prostate 
[10]; however, adjuvant chemotherapy is generally used. 
Although the need for adjuvant radiotherapy is con-
troversial, it should be considered if the pathologic report 
shows prostatic capsular invasion or resection marginal 
invasion. 
    In our patient, we performed robot-assisted laparoscopic 
radical prostatectomy and pelvic lymph node dissection. 
The patient did not undergo adjuvant radiotherapy but did 
receive adjuvant chemotherapy because no remaining can-
cer was reported by postoperative pathology, although it 
was reported that there had been metastasis in the right 
iliac lymph node and right obturator lymph node. At 9 
months after surgery, the cancer had not recurred and the 
patient’s urinary incontinence had improved compared 
with right after the surgery, with the use of ≤1 safety liner 
per day. A case of robot-assisted laparoscopic radical pros-
tatectomy together with adjuvant chemotherapy to treat 
primary small cell cancer of the prostate has not been re-
ported previously. Therefore, it may be valuable to study 
the clinical significance of this case through further fol-
low-up monitoring. 
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